Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipients

Kenneth C. Bilchick; Yongfei Wang; Jeptha P. Curtis; Alan Cheng; Kumar Dharmarajan; Ramin Shadman; Todd Dardas; Inder S. Anand; Lars H. Lund; Ulf Dahlström; Ulrik Sartipy; Aldo Maggioni; Christopher M. O’Connor; Wayne C. Levy

doi:10.1016/j.ahj.2019.12.017

Back

Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipients

Article 2019 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2009

Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population

Wayne C. Levy, Kerry L. Lee, Anne S. Hellkamp, Jeanne E. Poole, Dariush Mozaffarian, David T. Linker, Aldo Maggioni, Inder S. Anand, Philip A. Poole‐Wilson, Daniel P. Fishbein, George Johnson, Jill Anderson, Daniel B. Mark, Gust H. Bardy

Article2013

New developments in cardiac resynchronization therapy

Rajiv Sankaranarayanan, Rajaverma Visweswariah, David J. Fox

Article2024

Implantable Cardioverter Defibrillator and Resynchronization Therapy in Patients With Overt Chronic Kidney Disease

C. Varga, John G.F. Cleland, William T. Abraham, Professor Gregory Lip, Francisco Leyva, Parta Hatamizadeh

Article2013

A Handbook of Cardiac Resynchronization Therapy with Case Studies

Rajiv Sankaranarayanan, Graeme Kirkwood, Rajavarma Viswesvaraiah, A Zaidi

Article2023

What determines who gets cardiac resynchronization therapy in europe?

Paolo Gatti, Tonje Thorvaldsen, Lina Benson, Camilla Normand, Gianluigi Savarese, Ulf Dahlström, Aldo Maggioni, Lars H. Lund, Cecilia Linde, Kenneth Dickstein